The cardiovascular effects of intravenous anaesthetic doses of methadone were evaluated in 30 mongrel dogs breathing oxygen. One half of the dogs were unpremedicated (group B) and the other half(group A) received atropine 1.5 mg intramuscularly 20 minutes before infusion of methadone. After collection of control cardiovascular data dogs in both groups were given 0.3 rag. kg-L of methadone intravenously over a ten-minute period and cardiovascular dynamics were again recorded immediately following infusion and 20 minutes later. Following this 0.5 rag. kg-~ of methadone was infused over ten minutes and measurements were obtained as with the 0.3 rag. kg -~ dose. Data were recorded in a similar fashion before and following intravenous infusion of methadone 1.0, 1.5 and 2.0 rag-kg-~ in the same animals, so that after the final infusion each animal had rcceived a total accumulated dose of methadone 5.3 mg. kg -~ . Group A dogs had significantly higher heart rates, mean aortic pressures and cardiac output than group B dogs during control conditions and throughout the study. Group A dogs showed no change in any cardiovascular variable measured during or after infusion of methadone 0.3 or 0.5 mg-kg -~. Methadone 1.0, 1.5 and 2.0 mg. kg -~ produced slight (but similar) decreases in mean aortic blood pressure but did not change heart rate, cardiac output, pulmonary capillary wedge pressure, right atrial pressure or pulmonary systemic vascular resistance. In group B dogs methadone 0.5 rag. kg -* produced modest decreases in heart rate, cardiac output and aortic blood pressure. Infusion of methadone 1.0, 1.5 and 2.0 mg. kg -t (total doses of 1.8, 3.3 and 5.3 rag. kg -*) produced changes similar to those with 0.5 rag. kg -t of the compound in group B animals with the exception of heart rate, which was further decreased, and pulmonary vascular resistance, which was increased with 1.5 and 2.0 rag-kg -* infusions.
LARGE DOSES of intravenous morphine (2-3 mg-kg -I) produce little circulatory change in man and this drug has become popular as a "complete" anaesthetic and as a supplement in patients with little cardiac reserve, t-3 However, incomplete anaesthesia, 2 histamine release, 3'4 prolonged respiratory depression, TM venovasodilation with impaired venous return: antidiuresis ~ and cardiovascular depression when nitrous oxide is added to the inspired mixture 6 are problems associated with morphine anaesthesia. Recently, large doses of fentanyl (50-100 I~g kg -~) plus oxygen have also been reported to be effective as an anaesthetic in dogs and in patients with valvular and coronary artery disease. 7-9 Advantages of fentanyl over morphine as a "complete" anaesthetic include greater cardiovascular stability, no histamine release, no veno-vasodilation and less postoperative respiratory depression. Unfortunately large doses of fentanyl can result in occasional chest wall rigidity, especially when the compound is administered rapidly intravenously: In addition, although duration of respiratory depression is less after anaesthetic doses of fentanyl than after comparable doses of morphine, administration of large doses does necessitate postoperative mechanical assistance of respiration for two to eight hours after open-heart'operations, s '9 In an attempt to develop an intravenous narcotic anaesthetic which possesses the advantages of fentanyl and morphine with fewer of the disadvantages, our attention has been drawn to methadone. Methadone is an opiate with less addiction liability than morphine and is frequently used in the stabilization therapy of narcotic addicts. 1o-~6 Methadone is reported to be equal to or slightly more potent than morphine, does not produce chest wall rigidity or veno-vasodilation and, in preliminary studies in our laboratories, appears to be less depressing to respiration than morphine or fentanyl when administered intravenously in dogs. ~o- 16 Immediately after intubation, a teflon catheter was implanted into a femoral artery through a small groin incision and threaded 20 to 35 cm into the central aorta. A quadruple-lumen thermodilution catheter was placed in an external jugular vein and threaded into the right or left pulmonary artery. Cardiac output was measured using an Edwards model 9510 thermodilution cardiac output computer. Stroke volume was determined by dividing cardiac output by heart rate. Mean aortic, pulmonary artery, pulmonary capillary wedge and right atrial pressures were measured using Statham model P 23 Db pressure transducers. Systematic and pulmonary vascular resistances in dynes-sec/cm 5 were calculated according to the tollowing formulae: ) were not given atropine. After collection of control data, dogs inboth groups were given methadone 0.3 mg.kg -~ intravenously over a ten-minute period by a Harvard infusion pump. Heart rate, stroke volume, cardiac output, mean pulmonary artery, pulmonary capillary wedge, right atrial and aortic blood pressures and pulmonary and systemic vascular resistances were measured before methadone infusion, immediately following infusion and 20 minutes later. Following this, methadone 0.5 mg. kg -~ was infused in the same animals over a ten minute period for a total dose of methadone 0.8 mg.kg-' and measurements were done as with the 0.3 mg. kg-~ dose. Data were recorded in a similar fashion beforc and following intravenous infusion of methadone 1.0, 1.5 and 2.0 mg. kg -~ in the same animals, for total accumulated methadone doses of 1.8, 3.3 and 5.3 mg. kg -I.
Data were analyzed using Student's t-test for paired data for comparison to control values and Student's t-test for unpaired data for comparison of group A versus group B at each methadone dosage.
RESULTS
Group A dogs (atropine recipients) had significantly higher heart rates, mean aortic blood pressures and cardiac outputs than group B dogs during control conditions and throughout the study. All other cardiovascular variables were similar in both groups prior to methadone administration. Recordings for all cardiovascular variables measured were similar immediately following methadone infusion and 20 minutes later, irrespective of the dose of compound infused. Consequently, data obtained 20 minutes after methadone infusion do not appear in Table I .
Group A dogs showed no change in any variable measured with infusions of methadone 0.3 and 0.5 mg-kg -~ (Table I) . Following infusion of methadone 1.0 mg. kg -~ mean aortic blood pressure was slightly but significantly decreased (P < 0.05) but all other variables remained unchanged. Methadone infusions of 1.5 and 2.0mg.kg -t (total methadone doses of 3.3 and 5.3 mg. kg -~) did not produce further changes in aortic pressure or cardiac output nor did they result in significant alterations in any other variable measured in group A dogs.
Group B dogs had no significant change in any variable following methadone 0.3 mg.kg -I, but there were modest but significant (P < 0.05) decreases in heart rate, cardiac output and mean aortic blood pressure and an increased in systemic vascular resistance following 0.5 mg. kg -~ of the compound (Table I) . Mean pulmonary artery pressure, pulmonary capillary wedge pressure, right atrial pressure and pulmonary vascular resistance were not significantly changed by methadone 0.5 rag. kg -~. Methadone infusions of 1.0, and 1.5 and 2.0 rag. kg -~ (total doses of 1.8, 3.3 and 5.3 rag-kg-i) produced changes similar to those with 0.5 mg.kg -~ with the exception of heart rate, which was further decreased, and pulmonary vascular resistance, which was increased with 1.5 and 2.0mg.kg -t of the drug. When compared to group A dogs, group B dogs had significantly (P < 0.05) greater decreases in heart rate and cardiac output and increases in systemic vascular resistance after methadone infusions of 1.0 mg. kg -~ or more and greater increases in pulmonary vascular resistance after methadone 1.5 and 2.0 mg. kg-t.
DISCUSSION
Methadone (6-dimethylamino-4, 4 diphenyl-3-heptanone hydrochloride) has recently become popular in treatment of addiction and withdrawal programmes because of its minimal addiction potential. ~~ Although methadone does not produce euphoria, in contrast to morphine, it does provide sedation and analgesia, to-~6 Indeed, the analgesic potency of methadone has been reported to be from one and one half to four times that of morphine.t3-~5 While side effects following oral or parenteral administration of analgesic doses (5-10mg) of methadone are similar to those found after comparable doses of morphine (nausea and vomiting, pinpoint pupils, respiratory depression, dry mouth, itching, etc.) there is evidence that the incidence of these problems is less with the former than the latter. ~~ Considering the above, it is possible that large doses of methadone have advantages over large doses of morphine and even over large doses of fentanyl as art anaesthetic. Preliminary studies in this laboratory demonstrated that large intravenous doses of methadone (1.0 mg.kg -~ and above) plus oxygen produce adequate anaesthesia for thoracotomy in the dog. 16 However, the cardiovascular effects of these doses were not investigated in that study, The results of this investigation demonstrate that large intravenous doses of methadone, like large doses of morphine and fentanyl, produce only minimal changes in cardiovascular dynamics. In addition, our data indicate that most of the cardiovascular changes occurring after methadone in dogs can be reduced or eliminated by premedication with atropine as after fentanyl. ~ Large intravenous doses of morphine and fentanyl produce bradycardia, especially when the compounds are administered rapidly early in the anaesthetic procedure3 '7-9 Bradycardia after morphine, and probably also after fentanyl, occurs because of central medullary vagal stimulatlon. I~,t9 Methadone 0.5-2.0mg-kg -t caused significant decreases in heart rate when atropine was omitted in this study, but did not significantly change heart rate when our animals received atropine premedication. These findings suggest that methadone, like morphine and fentanyl, increases vagal tone.
Decreases in heart rate with methadone in this study were, as with anaesthetic doses of fentanyl in the dog, t7 the most important reason for reductions in cardiac output. When bradycardia was prevented (group A) cardiac output remained unchanged during and after methadone infusion. Absence of changes in cardiac output in group A and of stroke volume, pulmonary capillary wedge pressure and right atrial pressure in groups A and B indicate that large doses of methadone do not appreciably alter myocardial mechanics. If methadone acts similarly in man, it could be useful as an anaesthetic in patients with little cardiac reserve.
While our findings in this study suggest that anaesthetic doses of methadone, like morphine and fentanyl, produce little cardiac depression, they do not reveal whether these doses of the compound result in any problems. A number of years ago large doses of morphine with oxygen became popular as an anaesthetic technique for patients with poor cardiac reserve because the technique caused little change in cardiovascular dynamics in intact, supine man. However, incomplete anaesthesia, 2 increased blood requirements, 4 anti-diuresis, s and cardiovascular depression when combined with nitrous oxide ~ have been described as problems with morphineoxygen anaesthesia and, as a result, the popularity of this technique has decreased today. While our findings with methadone-oxygen anaesthesia in this study are encouraging, it is too soon to say what importance, if any, this technique may eventually assume in clinical anaesthesia. However, the findings in this study, when combined 56 with other available data, suggest that methadone deserves cautious evaluation as an anaesthetic in man.
SUMMARY CANADIAN ANAESTHETISTS' SOCIETY JOURNAL
The results of this study demonstrate that intravenous anaesthetic doses of methadone produce only minimal changes in cardiovascular dynamics, most of which can be avoided by prior administration of atropine. Our findings suggest that anaesthesia with intravenous methadone plus oxygen may be an attractive alternative to morphine in patients with little cardiac reserve and deserves clinical evaluation as an anaesthetic in man, la pression capillaire bloqu~e ou auriculaqire droite ainsi que les r~sistances vasculaires pulmonaire ou syst6mique. Chez les r du groupe B, la m&hadone (0.5 mg. kg-0 a produit de I~g~res diminutions de fr~quence, de d~bit cardiaque el de pression aortique moyenne. La perfusion de 1.0, 1.5 et 2.0 rag. kg -I de m&hadone (doses totales 1.8, 3.3 et 5.3 rag. kg -~) a produit les m~mes modifications que 0.5 rag-kg -~ du m~dicament chez les animau• du groupe B avec I'e• de la fr~quence qui a 6t~ plus ralentie et de la r6sistanee vasculaire pulmonaire qui a ~t6 augment6e aver des perfusions de 1.5 et 2.0 rag. kg -~. Ces donn~es montrent que des doses anesth~siques de m~thadone administr~es par la voie veineuse produisent peu de changements de la dynamique eardiovasculaire, et que r changements peuvent ~tre pr6venus pas I'administration pr~alable d'atropine. Ces donn~es autorisent h penser que la methadone intra-veineuse peat ~tre une alternative attrayante ~ la morphine r les patients dont la r6serve cardiaque est diminu6e et m~rite qu'on en d6bute I'~valuation clinique chez l'homme.
